Venture Capital Partners
Bioindustrial Innovation Canada and Fraser Mackenzie Merchant Capital have signed a Memorandum of Understanding (MOU) to facilitate cooperation between the two organizations.
FMMC is focused on helping medium sized businesses grow. Each of our partners has over 20 years’ experience in finance and operations related to medium sized Canadian business.
​
We make direct investments of $2-$10 million in cashflowing businesses across most industry sectors through our own funds. FMMC Buyout Fund focuses on privately owned businesses with enterprise values of $5 to $50 million and our FMMC Private Yield Fund focuses on making subordinated loans to both private and publicly traded companies with EBITDA ranging from $1.5 to about $15 million.
Not sure whether you need equity or debt? We do both, so can work with you to ensure the best fit for your specific business and owner situation. We also offer a comprehensive suite of Investment Banking and Advisory Services including mergers and acquisitions and helping boards and shareholders with a variety of other strategic advisory assignments.
Bioindustrial Innovation Canada and Cycle Capital Management have signed a Memorandum of Understanding (MOU) to facilitate cooperation between the two organizations.
Cycle Capital Management (CCM) is an impact investor and the most active cleantech venture capital firm in Canada. CCM invests in companies developing and commercializing clean technologies and striving to reduce greenhouse gas emissions, optimizing resource use, and improving process efficiency throughout a product’s life cycle.
​
With assets under management of $230M, CCM invests in North America. Headquarted in Montreal with offices in Toronto, New York, Seattle and Qingdao in China, CCM regroups seasoned investment professionals, strategic advisors and industrial partners with in-depth knowledge of the sector. Cycle Capital Management has a special relationship with its strategic partners, notably Brookfield Renewable Energy, Rio Tinto, Cascades, Group M3, Lonza, Gaz Métro, Systemex Énergies, Aluminerie Alouette, and Hydro-Québec.
Bioindustrial Innovation Canada and Sofinnova Partners have signed a Memorandum of Understanding (MOU) to facilitate cooperation between the two organizations.
Sofinnova Partners is an independent venture capital firm based in Paris, France. For more than 40 years, the firm has backed nearly 500 companies at different stages of their development – pure creations, spin-offs, as well as turnaround situations – and worked alongside key entrepreneurs in the Life Sciences industry around the globe. With over €1.6 billion of funds under management, Sofinnova Partners has created market leaders with its experienced team and hands-on approach in building portfolio companies through to exit.
Bioindustrial Innovation Canada and GreenSky Capital Inc., have signed a Memorandum of Understanding (MOU) to facilitate cooperation between the two organizations.
​
GreenSky Capital Inc. is an award-winning Toronto-based firm that provides merchant bank and corporate financial advisory services to small and medium sized technology firms within the IT, cleantech and medtech sectors. GreenSky looks for long-term partnerships with high-growth potential companies and dedicated entrepreneurs. GreenSky principals bring a unique combination of experience in technology, law and finance into a real-world context. GreenSky Capital makes investments in early-stage Canadian technology companies through its affiliated venture capital funds, GreenSky Accelerator Fund I, LP and GreenSky Accelerator Fund II, LP.
​
BIC and GSC have agreed to work together to exchange information, to establish business relations between their networks, and to develop research and development, demonstration projects, and commercialization for companies that provide clean, green and sustainable technologies.
​
Relationships with and between industrial, academic or governmental organizations will be established in order to initiate projects in research and development, demonstration and/or commercial partnering. BIC and GSC will jointly support the initiation of these projects and following due diligence may invest in companies on a collaborative or separate and individual basis.
Bioindustrial Innovation Canada and ArcTern Ventures., have signed a Memorandum of Understanding (MOU) to facilitate cooperation between the two organizations.
​
ArcTern Ventures (ATV), is a privately-backed Ontario –based venture capital fund which focuses on early stage investing in companies within cleantech markets. ATV is an established venture capital firm, partnered with the MaRS Discovery District, and has a diversified portfolio of investments across the cleantech sector. Additionally ATV provides advisory services and hands-on management.